Kenneth Gordon to Neutropenia
This is a "connection" page, showing publications Kenneth Gordon has written about Neutropenia.
Connection Strength
0.063
-
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med. 2016 Jul 28; 375(4):345-56.
Score: 0.032
-
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. N Engl J Med. 2015 Oct; 373(14):1318-28.
Score: 0.031